CASSAVA SCIENCES, INC.
SAVA · NASDAQ
Cassava Sciences' mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer's disease.
Market Data
Price
$1.45
+0.01 (+0.69%)
Market Cap$115M
P/E Ratio—
EPS$—
52W High$4.98
52W Low$1.45
Beta-0.71
Data from Finnhub · Updated May 1, 2026